Liver Cancer
EAL (Expanded Activated Lymphocytes) – HCC | HongKong DengYue Medicine
Likating (Iodine131I Metuximab) – HCC | HongKong DengYue Medicine
Cyramza (Ramucirumab) – NSCLC | HongKong DengYue Medicine
Cabometyx (Cabozantinib) – Solid Tumors | HongKong DengYue Medicine
Avastin (Bevacizumab) – mCRC & NSCLC | HongKong DengYue Medicine
Stivarga (Regorafenib) – Colorectal cancer | HongKong DengYue Medicine
YERVOY (Ipilimumab) – Advanced Malignancies | HongKong DengYue Medicine
Zepsun (Donafenib Tosilate) – HCC | HongKong DengYue Medicine
Oncorine (Recombinant Human Adenovirus 5 Injection) – Nasopharyngeal Carcinoma | HongKong DengYue Medicine
Tibsovo (Ivosidenib) – AML | HongKong DengYue Medicine
Pemazyre (Pemigatinib) – Cholangiocarcinoma | HongKong DengYue Medicine
Lenvima (Lenvatinib) – HCC | HongKong DengYue Medicine
Daboshu (Sintilimab Injection) – Lung Cancer | HongKong DengYue Medicine
Pradefovir Mesylate Tablets｜Liver Cancer｜HongKong DengYue Medicine
Sorafenib Tosylate Tablets | Thyroid cancer | HongKong DengYue Medicine
Compound Fluorouracil Oral Solution
